225 reports of this reaction
2.0% of all ENTACAPONE reports
#10 most reported adverse reaction
ON AND OFF PHENOMENON is the #10 most commonly reported adverse reaction for ENTACAPONE, manufactured by Ajanta Pharma USA Inc.. There are 225 FDA adverse event reports linking ENTACAPONE to ON AND OFF PHENOMENON. This represents approximately 2.0% of all 11,238 adverse event reports for this drug.
Patients taking ENTACAPONE who experience on and off phenomenon should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ON AND OFF PHENOMENON is a less commonly reported adverse event for ENTACAPONE, but still significant enough to appear in the safety profile.
In addition to on and off phenomenon, the following adverse reactions have been reported for ENTACAPONE:
The following drugs have also been linked to on and off phenomenon in FDA adverse event reports:
ON AND OFF PHENOMENON has been reported as an adverse event in 225 FDA reports for ENTACAPONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ON AND OFF PHENOMENON accounts for approximately 2.0% of all adverse event reports for ENTACAPONE, making it a notable side effect.
If you experience on and off phenomenon while taking ENTACAPONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.